In a regulatory filing, Vera Therapeutics disclosed that its director Maha Katabi bought 161.3K shares of common stock on January 30th in a total transaction size of $5.0M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VERA:
- Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
- Vera Therapeutics Announces $250M Public Stock Offering
- Vera Therapeutics 8.064M share Secondary priced at $31.00
- Vera Therapeutics Halts At-The-Market Stock Offering
- Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock